课题基金 / 基金详情

Caffeine as a Therapeutic Agent in Parkinson's disease

Caffeine as a Therapeutic Agent in Parkinson's disease
咖啡因作为帕金森病的治疗剂
批准号:
266514
负责人:
Postuma Ronald B
金额:
$42.67万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-09-01 至 2018-09-01

项目摘要

项目成果

Postuma Ronald B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Parkinson's disease is a common neurodegenerative disorder in which patients experience progressive motor disability and many disabling non-motor symptoms. Recent studies have consistently found that people who do not use caffeine are at higher risk of de
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuroimaging Prodromal Neurodegeneration in Synucleinopathy
Caffeine for Somnolence and Motor Manifestations of Parkinson's disease
Improving Detection and Management of Non-motor Features of Parkinson's disease - Development of a Knowledge Translation Outreach Strategy
海外基金